Response to "Poor control vaccines in two randomised trials of malaria vaccine?".

Response to "Poor control vaccines in two randomised trials of malaria vaccine?".

Bibliografski detalji
Glavni autori:	Bejon, P, Abdulla, S, Lusingu, J, Olotu, A, Leach, A, Lievens, M, Tanner, M, von Seidlein, L
Format:	Journal article
Jezik:	English
Izdano:	2009

Slični predmeti

RTS,S/AS01E Vaccine against Malaria THE AUTHORS REPLY
od: Bejon, P, i dr.
Izdano: (2009)

Approaching the community about screening children for a multicentre malaria vaccine trial.
od: Lang, T, i dr.
Izdano: (2012)

Approaching the community about screening children for a multicentre malaria vaccine trial
od: Lang, T, i dr.
Izdano: (2012)

Malaria vaccines: past, present and future.
od: von Seidlein, L, i dr.
Izdano: (2013)

Malaria vaccines: Past, present and future
od: Von Seidlein, L, i dr.
Izdano: (2013)

Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S/AS01 malaria vaccine in African children.
od: Lievens, M, i dr.
Izdano: (2011)

Efficacy of RTS,S malaria vaccines: Individual-participant pooled analysis of phase 2 data
od: Bejon, P, i dr.
Izdano: (2013)

A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine
od: White, M, i dr.
Izdano: (2014)

Feedback of Research Findings for Vaccine Trials: Experiences from Two Malaria Vaccine Trials Involving Healthy Children on the Kenyan Coast
od: Gikonyo, C, i dr.
Izdano: (2013)

Feedback of research findings for vaccine trials: experiences from two malaria vaccine trials involving healthy children on the Kenyan Coast.
od: Gikonyo, C, i dr.
Izdano: (2013)

PHASE IIB, RANDOMIZED, DOUBLE-BLIND TRIAL TO ASSESS THE EFFICACY, SAFETY AND IMMUNOGENICITY OF THE CANDIDATE MALARIA VACCINE RTS,S/AS01 IN KENYAN AND TANZANIAN CHILDREN
od: Bejon, P, i dr.
Izdano: (2008)

Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data.
od: Bejon, P, i dr.
Izdano: (2013)

Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children.
od: Bejon, P, i dr.
Izdano: (2011)

Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS,S/AS01 malaria vaccine in African children
od: Lievens Marc, i dr.
Izdano: (2011-08-01)

Further analysis of correlates of protection from a phase 2a trial of the falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults.
od: Olotu, A, i dr.
Izdano: (2010)

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.
od: Bejon, P, i dr.
Izdano: (2008)

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
od: Olotu, A, i dr.
Izdano: (2011)

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
od: Lusingu, J, i dr.
Izdano: (2010)

Seven year efficacy of RTS,S/AS01 malaria vaccine in young African children
od: Olotu, A, i dr.
Izdano: (2016)

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial.
od: Olotu, A, i dr.
Izdano: (2011)

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial
od: Olotu, A, i dr.
Izdano: (2011)

Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine.
od: Horowitz, A, i dr.
Izdano: (2012)

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
od: Ally Olotu, i dr.
Izdano: (2011-01-01)

Roll out and prospects of the malaria vaccine R21/Matrix-M.
od: Lorenz von Seidlein
Izdano: (2025-01-01)

The future of the RTS,S/AS01 malaria vaccine: an alternative development plan
od: Gosling, R, i dr.
Izdano: (2015)

The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan.
od: Roly Gosling, i dr.
Izdano: (2016-04-01)

Steps towards a malaria vaccine
od: Bejon, P
Izdano: (2005)

Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data.
od: Warimwe, G, i dr.
Izdano: (2013)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01 in 5 to 17 Month Old Kenyan and Tanzanian Children.
od: John Lusingu, i dr.
Izdano: (2010-01-01)

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
od: John Lusingu, i dr.
Izdano: (2010-11-01)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01 in 5 to 17 Month Old Kenyan and Tanzanian Children.
od: John Lusingu, i dr.
Izdano: (2010-01-01)

Long term efficacy of a pre-erythrocytic malaria vaccine and correlates of protection in children residing in a malaria endemic country
od: Olotu, A
Izdano: (2013)

A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults
od: Hanboonkunupakarn, B, i dr.
Izdano: (2024)

Malaria vaccine development: lessons from the field.
od: Todryk, S, i dr.
Izdano: (2009)

A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults
od: Borimas Hanboonkunupakarn, i dr.
Izdano: (2024-07-01)

Pre-vaccination monocyte-to-lymphocyte ratio as a biomarker for the efficacy of malaria candidate vaccines: A subgroup analysis of pooled clinical trial data.
od: Jane Paula Nyandele, i dr.
Izdano: (2023-01-01)

Pre-vaccination monocyte-to-lymphocyte ratio as a biomarker for the efficacy of malaria candidate vaccines: A subgroup analysis of pooled clinical trial data
od: Jane Paula Nyandele, i dr.
Izdano: (2023-01-01)

Correction: Malaria vaccine development: Lessons from the field
od: Todryk, S, i dr.
Izdano: (2011)

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
od: Datoo, MS, i dr.
Izdano: (2024)

Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group.
od: Nosten, F, i dr.
Izdano: (1996)